Preeclampsia aftermath: new study tracks heart and kidney risks

NCT ID NCT07151339

Recruiting now Knowledge-focused Sponsor: University Hospital Schleswig-Holstein Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study follows 100 women who had preeclampsia, HELLP syndrome, or kidney problems during pregnancy. Researchers will measure blood vessel stiffness and collect blood samples for a biobank. The goal is to better understand long-term heart and kidney health after these conditions. No new treatments are being tested.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this study could help design better long-term health monitoring programs for women who had preeclampsia.
What could go wrong: This is an observational study, not a treatment trial. It will not directly improve health outcomes, and results may take years to translate into practice.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ECLAMPSIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

eclampsia HELLP syndrome impaired renal function disease kidney disorder preeclampsia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ECLAMPSIA HELLP SYNDROME KIDNEY DISEASE PREECLAMPSIA

Contacts and locations

Locations

University Hospital Schleswig- Holstein
RECRUITING

Kiel, 24105, Germany

More trials for these conditions

Other studies related to the condition(s) this trial covers.